Skip to main navigation Skip to search Skip to main content

Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.

  • C. Koenecke
  • , N. Czeloth
  • , A. Bubke
  • , S. Schmitz
  • , Adrien Kissenpfennig
  • , B. Malissen
  • , J. Huehn
  • , A. Ganser
  • , R. Förster
  • , I. Prinz

Research output: Contribution to journalArticlepeer-review

24 Downloads (Pure)
Original languageEnglish
Pages (from-to)3091-3096
Number of pages6
JournalEuropean Journal of Immunology
Volume39(11)
Issue number11
DOIs
Publication statusPublished - Nov 2009

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this